Licenses & Certifications

Ambry Genetics is both CAP-accredited and CLIA-approved. Ambry is able to conduct genetic testing on samples received from any state in the US. In addition, Ambry has special licensure from the states listed below. 

Licensing & Regulatory Number Expiration Date
CAP Accredited 7154701 October 26, 2016
CLIA Approved 05D0981414 May 29, 2018
State of California CLF 00011694 April 28, 2017
State of Florida 800016789 January 28, 2018
State of Maryland 1052 June 30, 2017
State of New York PFI: 8160 December 31, 2016
State of Rhode Island LCO00439 December 30, 2017
State of Pennsylvania 027832A August 15, 2016
Notice of Privacy Practices    
Federalwide Assurance for the Protection of Human Subjects FWA#: FWA00024430 July 26, 2021

 

Proficiency Testing
Ambry Genetics participates in Proficiency Testing provided by the College of American Pathologists (CAP) for all available tests and performs Alternative Proficiency Testing where CAP does not provide an offering. In support of our International clients, Ambry also participates in the United Kingdom National External Quality Assessment Services (UK NEQAS) Molecular Genetics quality assessment schemes. Ambry’s Proficiency Testing program is essential in order to ensure nationally and internationally agreed upon consensus and/or standards in clinical laboratory testing are met.